Literature DB >> 8246860

Resurgence of pertussis--United States, 1993.

.   

Abstract

From January 3 through December 4, 1993 (weeks 1-48), 5457 pertussis cases were reported to CDC--an 82% increase over the number reported during the same period in 1992 (3004) and the highest annual number of cases reported since 1967 (Figure 1). Compared with 1992, the number of reported pertussis cases increased in 35 states, especially those in the New England, middle-Atlantic, North Central, and Mountain regions (Figure 2). During 1993, large outbreaks have occurred in Chicago and Cincinnati. This report summarizes epidemiologic characteristics of pertussis cases reported through December 4, 1993.

Mesh:

Substances:

Year:  1993        PMID: 8246860

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  11 in total

1.  Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis.

Authors:  Terri H Hardwick; Brian Plikaytis; Pamela K Cassiday; Gary Cage; Mark S Peppler; Deborah Shea; David Boxrud; Gary N Sanden
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Pertussis in Florida, 2000-2006: trends in a historically low-incidence state.

Authors:  Joann M Schulte; Robyn Kay; Janet J Hamilton; Cathy Mellinger; Phyllis Yambor; Christie Luce; Dawn Ginzl; Julia Gill; Richard S Hopkins
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

3.  Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii.

Authors:  U Reischl; N Lehn; G N Sanden; M J Loeffelholz
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.

Authors:  J B Bruss; G R Siber
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 5.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Masseteric silent period in healthy young adults.

Authors:  B R Pousa; L da Silva Domínguez; M J Mora Bermúdez; A M Insua; U Santana Penín
Journal:  Bull Group Int Rech Sci Stomatol Odontol       Date:  1999 Apr-Sep

7.  Issues associated with and recommendations for using PCR to detect outbreaks of pertussis.

Authors:  Fabio A Lievano; Meredith A Reynolds; Alfred L Waring; Joel Ackelsberg; Kristine M Bisgard; Gary N Sanden; Dalya Guris; Anne Golaz; Dianna J Bopp; Ronald J Limberger; Perry F Smith
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 8.  Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.

Authors:  Varun K Phadke; Robert A Bednarczyk; Daniel A Salmon; Saad B Omer
Journal:  JAMA       Date:  2016-03-15       Impact factor: 56.272

9.  Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.

Authors:  Jon B Bruss; George R Siber
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Pertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008).

Authors:  Maria Theodoridou; Georgia Dargenta; Maria Aptouramani; Panagiotis Papastergiou; Anna Katsiaflaka; Kalliopi Theodoridou; Christos Hadjichristodoulou
Journal:  Adv Prev Med       Date:  2012-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.